Actively Recruiting

Phase Not Applicable
Age: 3Years - 12Years
All Genders
Healthy Volunteers
NCT07154992

Clinical Trial to Evaluate the Efficacy of Lacticaseibacillus Rhamnosus CRL1505 in the Prevention of Upper Respiratory Tract Infections in Children

Led by Bioithas SL · Updated on 2025-09-12

268

Participants Needed

1

Research Sites

119 weeks

Total Duration

On this page

Sponsors

B

Bioithas SL

Lead Sponsor

C

Centro Sperimentale del Latte S.r.l.

Collaborating Sponsor

AI-Summary

What this Trial Is About

Randomized, double-blind, placebo-controlled, parallel-group, clinical trial to assess the efficacy of the intake of a probiotic product composed of Lacticaseibacillus rhamnosus CRL1505 strain in reducing or preventing upper respiratory tract infections (URTIs) in a healthy paediatric population.

CONDITIONS

Official Title

Clinical Trial to Evaluate the Efficacy of Lacticaseibacillus Rhamnosus CRL1505 in the Prevention of Upper Respiratory Tract Infections in Children

Who Can Participate

Age: 3Years - 12Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy children aged 3 to 12 years
  • Signed informed consent from parents
Not Eligible

You will not qualify if you...

  • Chronic diseases such as asthma, chronic bronchitis, heart, neurological, liver, kidney, gastrointestinal, or hematological disorders
  • Metabolic disorders including diabetes mellitus and obesity
  • Immunodeficiency, including HIV infection or chronic corticosteroid use
  • Nasal polyps, nasal ulcers, or other nasal obstruction conditions
  • Regular use of medications or supplements that may affect study results within 4 weeks prior, including immunosuppressants, immunostimulants, analgesics, anti-inflammatory drugs, antitussives, flu preparations, decongestants, antibiotics, antihistamines, and probiotics

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

MiBioPath Research Group (UCAM)

Murcia, Spain

Actively Recruiting

Loading map...

Research Team

J

Juan Gabriel Agüera Santos

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here